News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections tests and treatment news

Show

From To
Sexually transmitted infections tests and treatment
How dangerous is gonorrhoea resistance and can it be halted?

The bacterium that causes the common sexually transmitted infection (STI) gonorrhoea develops resistance to antibiotics easily, and some cases of multidrug-resistant gonorrhoea, originating from abroad, were reported

Published
06 December 2018
By
Gus Cairns
Sexually transmitted infections tests and treatment
Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Published
04 September 2018
From
ECDC
Sexually transmitted infections tests and treatment
'World's worst' super-gonorrhoea man cured

The patient had a lucky escape say doctors, but now two more cases have been discovered.

Published
23 April 2018
From
BBC Health
Sexually transmitted infections tests and treatment
The recent trend towards multi-resistant gonorrhoea in coastal China

Alarming data have recent been reported (Yin & Chen) (Y&C) from the China Gonococcal Resistance Surveillance Programme (China-GRSP), covering seven (mostly coastal) provinces in the period 2013-2016. The study is relevant for Chinese national treatment policy, which currently recommends azithromycin monotherapy. However, with an estimated 45% of the world’s 78 million incident cases occurring in [...]Read More...

Published
29 March 2018
From
BMJ Group blogs
Sexually transmitted infections tests and treatment
Gonorrhoea strains across Europe becoming more susceptible to main treatment options

According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010. However, resistance to one antibiotic agent which is part of the suggested dual therapy of gonorrhoea remains high and threatens the effectiveness of this regimen.

Published
29 August 2017
From
ECDC
Sexually transmitted infections tests and treatment
Sign-on Letter in Response to Critical Shortage of Penicillin for Syphilis Treatment in U.S.

Sign-on letter to Pfizer urging an immediate response to the nationwide shortage of penicillin G benzathine, the standard treatment for primary and secondary syphilis.

Published
10 July 2017
From
Treatment Action Group
Finance and funding
Cuts to sexual health services will lead to STI 'explosion', warn experts

Labour analysis predicts £40m less will be spent on testing and treating infection in 2016 despite rates of gonorrhoea and syphilis soaring.

Published
04 January 2016
From
The Guardian
Sexually transmitted infections tests and treatment
Gonorrhoea 'could become untreatable'

Gonorrhoea could become an untreatable disease, England's top doctor warns, amid concerns some pharmacies are not prescribing for it properly. Dame Sally Davies has written to all GPs and pharmacies to ensure they are prescribing the correct drugs after the rise of "super-gonorrhoea" in Leeds.

Published
27 December 2015
From
BBC Health
Sexually transmitted infections tests and treatment
Can we ensure adherence to STI treatment guidelines in a world threatened by antimicrobial resistance?

Sexual health care in the UK has traditionally centred on specialist GUM (genito-urinary medicine) services. Since the turn of the twenty-first century primary care has played an increasing role, however. The 2012 Health and Social Care Act is in line with this tendency, with most GP practices now being commissioned to provide level 1 STI screening. Questions have recently been raised about the conformity of care provided by GPs to national guidelines, established for the UK by the British Association for Sexual Health and HIV. In a world where Gonorrhoea – and perhaps one day Chlamydia – is set to become increasingly hard to treat, the problem of ensuring the conformity of generalists to universal standards of treatment is unlikely to go away.

Published
26 August 2015
From
BMJ
Sexually transmitted infections tests and treatment
Drug-resistant gonorrhoea rates plummet in US

Preliminary results announced at the US 2014 STD Prevention Conference in Atlanta have shown that the proportion of cases of gonorrhoea that are drug-resistant has fallen since 2011,

Published
16 June 2014
By
Gus Cairns
← Prev12345...6Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.